Common Contracts
1 similar null contracts
ContractNovember 30th, 2022
CLINICAL TRIAL AGREEMENT Study: A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER). Protocol: ANT-007 (incorporated by reference herein). STUDY DRUG: Abelacimab (MAA868). This Clinical Trial Agreement(together with Exhibit A, the “Agreement”) shall come into force upon its disclosure in the agreements register (the “Effective Date”), by and among: Anthos Therapeutics, Inc., with an address at 55 Cambridge Parkway, Suite 103, Cambridge, MA 02142 USA (“Sponsor”); Thomayer University Hospital, with registered office at Vídeňská 800, 140 59 Pragueha 4, Krč, Czech Republic, - , a state contributory organization established by the Ministry of Health of the Czech Republic, full wording of the organizational deed under file no. MZDR 17268- IV/2012, registered in Commercial Register of the Municipal Court in
